Home page > Products > Kengrexal®

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Kengrexal®

Active Ingredient: cangrelor

Cangrelor is a direct P2Y12 platelet receptor antagonist administered parenterally during intervention. Co-administered with acetylsalicylic acid (ASA), is indicated for the reduction of thrombotic cardiovascular events in adult patients with undergoing percutaneous coronary intervention (PCI).